• Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, 430070, P.R.China;
YANG Jianguo, Email: 979638260@qq.com
Export PDF Favorites Scan Get Citation

Objective To discuss the effect of Cabrol in treatment of Stanford type A aortic dissection.Methods The clinical data of patients whom were diagnosed with type A aortic dissection of Stanford in our hospital from January 2013 to January 2018 were retrospectively analyzed. All of 40 patients underwent Cabrol surgical procedure. There were 31 males and 9 females aged 26–75 (48.8±3.3) years. The surgical treatment effect of the patients was evaluated, mainly including the aortic index, the changes in cardiac function before and after operation, and the postoperative follow-up.Results All the 40 patients completed the operation successfully. The diameter of ascending aorta and aortic sinus in postoperative patients were smaller than those before operation (P<0.05). Postoperative left ventricular ejection fraction and cardiac output increased, central venous pressure and left ventricular end-diastolic dimension decreased, and cardiac function indexes were significantly different from those before the operation (P<0.05). Seven patients suffered complications in postoperative follow-up including one stenting leakage, three neurological diseases and three acute renal failure. Two patients died postoperatively.Conclusion Cabrol’s operation is effective in the treatment of Stanford type A aortic dissection, which can significantly improve the cardiac function of patients, simplify the anastomosis of coronary artery ostia and decrease amount of bleeding.

Citation: YANG Jianguo, ZHAO Jinping, XU Ming, ZHANG li. The effect of Cabrol in treatment of Stanford type A aortic dissection. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2019, 26(7): 670-673. doi: 10.7507/1007-4848.201810007 Copy

  • Previous Article

    Different surgical procedures for Stanford type A aortic dissection: A case control study
  • Next Article

    Clinical analysis of extracorporeal membrane oxygenation for 26 adult patients after cardiac surgical procedures